Posted inComunicati
EUROPEAN COMMISSION APPROVES AMGEN’S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction…








